Monopar Therapeutics Inc. MNPR
70.32 USD -1.59 -2.21%
At close · Oct 30
70.32 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
50.07 52-week range 124.82
- YTD
- +7.69%
- 1 year
- -17.92%
- Open
- 71.36
- Prev close
- 71.91
- Mkt cap
- 472.00M
- Vol
- 197.76K
- Avg vol
- 171.66K
- EPS
- -2.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 69.35
- High
- 72.76
- Forward P/E
- -10.17
- Beta
- 1.10
- Short ratio
- 0.15
- Inst. own
- 24.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 17.85
- 200-d avg
- 7.12
- 1y target
- 27.33
MAX chart
Chart tools
Chart is warming up
The all-time price history for MNPR has not been loaded yet. Try again in a moment.
Altman Z-Score
68.36 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
P/E -35.3×
P/S 0.0×
P/B 3.5×
P/FCF -39.7×
EV/EBITDA -30.8×
EV/Sales 0.0×
FCF Yield -2.5%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -10.0%
ROIC -12.1%
ROA -9.7%
Revenue 0.0%
Operating Income -3.4%
EPS (diluted) -36.0%
Free Cash Flow -90.5%
Current Ratio 51.4×
Quick Ratio 51.4×
Debt / Equity 0.0×
Net Debt / EBITDA 4.5×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31